The Massachusetts Life Sciences Center (MLSC) announced a $4.1 million capital grant to the Forsyth Institute for a newly-created Forsyth Center for Salivary Diagnostics (FCSD). The grant will support the construction and equipping of the FCSD, a facility that will seek to revolutionize the way disease testing is performed. In addition, the MLSC announced in December, 2012, more than $400,000 in equipment and supply grants to a vocational technical school and workforce development programs in Cambridge.
Through the MLSC, Massachusetts is investing $1 billion over 10 years in the growth of the state's life sciences supercluster. These investments are being made under the Massachusetts Life Sciences Initiative, passed by the State Legislature and signed into law by Governor Patrick in 2008.
"Through our investments in education, innovation and infrastructure Massachusetts leads the world in the life sciences," said Governor Deval Patrick. "That leadership has led and will lead to more jobs."
The FCSD will develop and commercialize saliva-based tests to replace costly and inconvenient blood-based disease detection tests that are currently used. Saliva contains virtually all of the same medical diagnostic information as blood, including DNA, proteins, hormones, etc., but is easily obtained non-invasively and painlessly, thus making it the approach of choice for people of all ages.
"The MLSC grant to create the Forsyth Salivary Diagnostic Center has the potential to revolutionize health care, by creating new opportunities for early disease detection and prevention," said Dr. Philip Stashenko, President & CEO of the Forsyth Institute. "Saliva is the mirror to the body, and Forsyth is the world leader in innovative research linking oral and overall health. We will generate new saliva-based diagnostics that can be used in diagnostic laboratories but in addition, by people to monitor their own health."
When completed, the F
|Contact: Jennifer Kelly|